Grantham, Mayo, Van Otterloo & Co (GMO)
GRTS

Grantham, Mayo, Van Otterloo & Co (GMO)’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,500
Closed -$41K – 896
2020
Q3 		$41K Buy
15,500
+1,300
+9% +$4.83K ﹤0.01% 755
2020
Q2 		$94K Buy
+14,200
New +$95.6K ﹤0.01% 726

Other funds holding GRTS

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s GRTS Position: Q4 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2020, closing a stake of 15,500 shares — an estimated $41K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in GRTS in Q2 2020 and held it in 2 quarters. The position peaked at $94K in Q2 2020. 71 funds tracked by Wall St. Rank hold GRTS as of Q4 2020.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 15,500 Gritstone bio, Inc. Common Stock shares in Q4 2020, an estimated $41K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Gritstone bio, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Gritstone bio, Inc. Common Stock position peaked at $94K in Q2 2020.
  • 71 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2020, filed 12 Feb 2021.